Why the study?
Does N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) reduce tolerance development compared to nitroglycerin in rats?
Does N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) reduce tolerance development compared to nitroglycerin in rats?
SG-75, a novel coronary vasodilator, demonstrates significantly less tolerance development compared to nitroglycerin in preclinical rat models.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for SG-75 as low-tolerance nitrate; clinical trials needed before any human use.
Tolerance to N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) and nitroglycerin (NTG) was studied in rats with regard to the blood pressure responses in vivo and thoracic aorta strip preparations in vitro. Tolerance to the blood pressure response to SG-75 or NTG was observed with consecutive subcutaneous administrations of high doses of SG-75 or NTG, three times a day and the tolerance was time- and dose-dependent. In strips of the aorta incubated for 30 min with SG-75, sensitivity to challenging doses of SG-75 remained unchanged, but in the preparations incubated with NTG, the response to challenging doses of NTG was greatly decreased. SG-75 developed no cross tolerance to NTG. In in vivo experiments, SG-75 developed only slight tolerance, but in the in vitro experiments, unlike NTG, induced no tolerance.
No takes yet. Share an insight, caveat, or question.
Nabata et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: